AMPH: Amphastar Pharmaceuticals Inc Sotuvning sof marjinal rentabelligi

amphastar.com (AMPH) grafik logotipi

Amphastar Pharmaceuticals (AMPH) murakkab inyeksiyalar va generik dori vositalarini ishlab chiqarish orqali risklarni minimallashtiradi. Strategiyaning samaradorligi sof foyda marjasi bilan tasdiqlanadi, bunda ko'rsatkich 13.30 ni tashkil etadi. Biznes ishlab chiqarish zavodlari ustidan ichki nazoratni saqlagan holda, dastlabki bosqichdagi sinovlarni autsorsing qilishga tayanadi. Daromadlar barqarorligi nomuvallik tizimlariga bo'lgan talabga va xomashyo ta'minoti zanjirlarida tartibga soluvchi standartlarga qat'iy rioya qilinishiga asoslangan.

Amphastar Pharmaceuticals (AMPH) - Sotuvning sof marjinal rentabelligi 04.07.2022dan 19.11.2026gacha

Amphastar - tahliliy kesimlar va asosiy koʻrsatkichlar (AMPH)

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning dastlabki tahlili:Amphastar Pharmaceuticals
Amphastar Pharmaceuticals Inc tayyor mahsulotlari

Eski dori vositalari narxlarining pasayishi xavfi va yangi generik dori vositalari uchun tartibga soluvchi organlar tasdiqlashining kechikishi Amphastar Pharmaceuticals (AMPH) aktivlarining monetizatsiya samaradorligiga bevosita ta'sir qiladi. Yillik sof marjalarning tahlili har bir savdo kuni uchun tushumning yakuniy foyda ulushini baholash imkonini beradi va ushbu investitsiya aktivining daromadliligi barqaror ekanligini yoki investitsiya xarajatlarining vaqtincha qisqarishi natijasi ekanligini ochib beradi.

Amphastar Pharmaceuticals kimlar bilan raqobatlashadi

HLN: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi KVUE|Sof marja veronapharma.com|Sotuvning sof rentabelligi MENS (Jyong Biotech Corp)|Sof marja Ligand (LGND)|Sotuvning sof marjinal rentabelligi amneal.com (AMRX)|Sotuvning sof marjinal rentabelligi PRGO (perrigo.com)|Alvotech SA (ALVO) - Sof marja|Liquidia Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Sof marja|Sotuvning sof rentabelligi MNKD|PCRX (Pacira Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ARS Pharmaceuticals, Inc. (SPRY)|Sotuvning sof marjinal rentabelligi TBPH|AQST (Aquestive Therapeutics) - Sof foyda normasi|scPharmaceuticals, Inc. - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi TECX|tonixpharma.com - Sotuvning sof marjinal rentabelligi|Sof foyda normasi SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi BioHarvest|Sof foyda bo'yicha sotuv rentabelligi EXOZ|Sof foyda bo'yicha sotuv rentabelligi Oramed Pharmaceuticals (ORMP)|Sof foyda bo'yicha sotuv rentabelligi ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi ABVC (ABVC BioPharma Inc)|CPIX - Sof foyda bo'yicha sotuv rentabelligi|Quantum BioPharma Corp - Sotuvning sof marjinal rentabelligi|FGEN (fibrogen.com) - Sotuvning sof rentabelligi|TELO (Telomir Pharmaceuticals) - Sof foyda bo'yicha sotuv rentabelligi|Rani Therapeutics Holdings - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi SNYR|Sof marja rallybio.com RLYB|Sotuvning sof marjinal rentabelligi LEXX|PULM (Pulmatrix, Inc.) - Sof foyda normasi|Pheton Holdings - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Aptorum Group Limited APM|LYRA: Sof foyda bo'yicha sotuv rentabelligi|IBO: Sof marja|TNFA: Sotuvning sof marjinal rentabelligi|YCBD: Kompaniyaning sof rentabelligi|Sof marja PainReform Ltd|CYTO (altamiratherapeutics.com) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi LIPO|OPTN - Sof marja|Sof marja pieris.com PIRS|Sof foyda normasi PROC|PTPI - Sof marja|Qilian International Holding (QLI) - Sof foyda bo'yicha sotuv rentabelligi|SLRN: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TFF Pharma